Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

February 4, 2025) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) securities between November 2, 2023 and ...

Taking a compounded GLP-1 medication isn’t the same thing as your pharmacy filling a cheaper, generic version of the drug ...

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...

Baron Funds, an investment management company, released its “Baron Small Cap Fund” fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here.

On April 10, 2024, the U.S. Department of Justice announced it had filed a complaint against Regeneron under the False Claims Act. According to the DOJ, the Company failed to report millions of ...

DS Smith, an international fibre-based packaging solutions company, has launched TailorTemp, a new temperature-controlled packaging solution, for the pharmaceutical industry. The product was unveiled ...

DS Smith, an international fibre-based packaging solutions company, has launched TailorTemp, a new temperature-controlled packaging solution, for the pharmaceutical industry. The product was ...

“We will be turning a lot of these cards during the year,” Hoppenot said during an interview with Fierce Pharma on the sidelines ... as an “opportunistic product” for parts of the world ...

To sustain this momentum and achieve the government’s $50 billion export target by 2030, it is essential to promote exports of pharma product as well as research and manufacturing services.

House Republicans are gearing up to enact a long list of health policy priorities now that the party holds all levers of power in Washington, but they face a steep set of obstacles to quick successes.